Yu, J., et al. 2022. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. Journal of Autoimmunity 133: 102916.

Article  PubMed  CAS  Google Scholar 

Armstrong, A. W., et al. 2021. Psoriasis Prevalence in Adults in the United States. JAMA Dermatology 157 (8): 940–946.

Article  PubMed  Google Scholar 

Brockbank, J. E., et al. 2005. Dactylitis in psoriatic arthritis: A marker for disease severity? Annals of the Rheumatic Diseases 64 (2): 188–190.

Article  PubMed  CAS  Google Scholar 

Gottlieb, A., et al. 2008. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. Journal of the American Academy of Dermatology 58 (5): 851–64.

Article  PubMed  Google Scholar 

Benham, H., et al. 2013. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Research & Therapy 15 (5): R136.

Article  Google Scholar 

Kirkham, B. W., A. Kavanaugh, and K. Reich. 2014. Interleukin-17A: A unique pathway in immune-mediated diseases: Psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 141 (2): 133–142.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ahmad, S. F., et al. 2014. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model. Cytokine 68 (2): 76–85.

Article  PubMed  CAS  Google Scholar 

Ahmad, S. F., et al. 2016. The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3(+) regulatory T cells during pathogenesis of rheumatoid arthritis. Molecular Immunology 78: 65–78.

Article  PubMed  CAS  Google Scholar 

Abd-Allah, A. R., et al. 2014. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. International Immunology 26 (6): 325–340.

Article  PubMed  CAS  Google Scholar 

Hidai, C., et al. 1998. Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes & Development 12 (1): 21–33.

Article  CAS  Google Scholar 

Choi, E. Y., et al. 2008. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322 (5904): 1101–1104.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang, H., et al. 2021. Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis. The Journal of Clinical Investigation 131: 19.

Article  Google Scholar 

Shin, J., et al. 2015. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Science Translational Medicine 7 (307): 155.

Article  Google Scholar 

Niu, X., et al. 2020. Psoriasis-associated angiogenesis is mediated by EDIL3. Microvascular Research 132: 104056.

Article  PubMed  CAS  Google Scholar 

Chen, M. F., et al. 2023. The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development. Bone & Joint Research 12 (12): 734–746.

Article  Google Scholar 

Yin, Z., et al. 2024. EDIL3/Del-1 prevents aortic dissection through enhancing internalization and degradation of apoptotic vascular smooth muscle cells. Autophagy  1–21.

Kourtzelis, I., et al. 2019. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nature Immunology 20 (1): 40–49.

Article  PubMed  CAS  Google Scholar 

Jia, M., et al. 2024. DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma. Allergy 79 (5): 1180–1194.

Article  PubMed  CAS  Google Scholar 

Kwak, N., et al. 2024. Del-1 Plays a Protective Role against COPD Development by Inhibiting Inflammation and Apoptosis. International Journal of Molecular Sciences 25 (4): 1955.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hagert, C., et al. 2019. Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure. Clinical and Experimental Immunology 196 (3): 383–391.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Khmaladze, I., et al. 2014. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proceedings of the National Academy of Sciences U S A 111 (35): E3669–E3678.

Article  CAS  Google Scholar 

Schett, G., et al. 2022. Psoriatic arthritis from a mechanistic perspective. Nature Reviews Rheumatology 18 (6): 311–325.

Article  PubMed  CAS  Google Scholar 

Coutant, F. 2021. Shaping of Monocyte-Derived Dendritic Cell Development and Function by Environmental Factors in Rheumatoid Arthritis. International Journal of Molecular Sciences 22 (24): 13670.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sanchez-Rodriguez, G., and L. Puig. 2023. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. International Journal of Molecular Sciences 24 (12): 10305.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Blauvelt, A., and A. Chiricozzi. 2018. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clinical Reviews in Allergy and Immunology 55 (3): 379–390.

Article  PubMed  CAS  Google Scholar 

Wei, X., et al. 2022. EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization. Cardiovascular Research 118 (9): 2179–2195.

Article  PubMed  CAS  Google Scholar 

Lowes, M. A., M. Suarez-Farinas, and J. G. Krueger. 2014. Immunology of psoriasis. Annual Review of Immunology 32: 227–255.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Riol-Blanco, L., et al. 2014. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 510 (7503): 157–161.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Preite, S., et al. 2019. T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity. Immunological Reviews 291 (1): 154–173.

Article  PubMed  CAS  Google Scholar 

Panneerpandian, P., and K. Ganesan. 2023. PI3K/AKT/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors. Medical Oncology 40 (4): 120.

Article  PubMed  CAS  Google Scholar 

Zuo, J. H., et al. 2011. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. Journal of Cellular Biochemistry 112 (9): 2508–2517.

Article  PubMed  CAS  Google Scholar 

Johnston, A., et al. 2011. cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinase. American Journal of Physiology. Gastrointestinal and Liver Physiology 301 (2): G385-400.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lv, S., et al. 2019. PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway. BMC Cancer 19 (1): 204.